Close Menu

NEW YORK – BGI Genomics said on Friday that its US subsidiary, BGI Americas, has been granted Emergency Use Authorization from the US Food and Drug Administration for its assay to detect SARS-CoV-2, the virus that causes COVID-19.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.